Top Study: 27% of Vaxxed Have Heart Damage
Apr 5, 2024 21:03:39 GMT -5
Post by schwartzie on Apr 5, 2024 21:03:39 GMT -5
Top Study: 27% of Vaxxed Have Heart Damage
Frank Bergman
April 5, 2024 - 12:54 pm
A top study conducted by a team of renowned microbiologists and immunologists has found that 27 percent of people vaccinated with Covid mRNA shots have damaged hearts.
The scientists found that many patients suffered major cardiac-related complications up to and over a year after receiving a Covid injection.
The study was led by microbiologist and immunologist Muazzam M. Sheriff and colleagues at Saudi Arabia’s Ibn Sina National College for Medical Studies and King Faisal General Hospital.
The results of the peer-reviewed study were published in the world-renowned Cureus medical journal.
Over a quarter of the participants in the study reported cardiac complications after receiving Covid mRNA shots.
Many of those patients required hospitalization or intensive care.
However, the scientists note that the study only recorded those who reported suffering cardiac-related complications.
Heart damage such as myocarditis often doesn’t have any symptoms until the sufferer experiences a major health issue such as cardiac arrest.
Therefore, the scientists warn that the true number of vaccinated people with heart damage could be far higher than they recorded due to the likelihood of large numbers of unreported cases.
Myocarditis is inflammation of the heart muscle (myocardium), according to Mayo Clinic.
The inflammation can reduce the heart’s ability to pump blood.
Severe myocarditis weakens the heart so that the rest of the body doesn’t get enough blood.
Clots can form in the heart, leading to a stroke, heart attack, or sudden death.
Experts now fear that undetected heart damage could be serving as a ticking time bomb among the Covid vaccinated.
The new study by Sheriff et al. revealed that 27.11% of the individuals they examined had received medical treatment for heart-related issues post-Covid vaccination.
The onset of cardiac complications varied among participants.
14.55% experienced symptoms within one month of vaccination.
However, others report issues up to 12 months or longer after receiving the shot.
The study warns that the findings suggest that the heart does not recover from the damage caused by the injections as previously claimed.
TrialSite News reported on the “bombshell Saudi Arabian study” this week.
Founder Daniel O’Connor stated that “the rate of hospitalized cases was certainly notable, especially given the existing cardiac (myocarditis/pericarditis) signal associated with the vaccines.”
Cardiologist and epidemiologist Dr. Peter A. McCullough said that in addition to the large number of cardiovascular symptoms warranting hospitalization, 15.8% landed in an intensive care unit (ICU).
“More than half of subjects indicated they were influenced by a healthcare professional or government agency to get vaccinated,” McCullough told The Defender.
“Never in recent times has there been such a cardiotoxic vaccine released on the public.”
Highlighting the growing concern surrounding the potential long-term effects of COVID-19 vaccines on cardiovascular health, O’Connor said:
“The surge in cardiac-related incidents in the news over the last year or two doesn’t comfort one either.”
The Saudi Arabian study employed a cross-sectional design and recruited 804 participants (379 men, and 425 women, ages 18 and above).
The participants had received at least one dose of an mRNA COVID-19 vaccine (Pfizer-BioNTech, Moderna, or both — 58 took a different brand).
Alarmingly, 40% of the participants had only received one shot.
Participants completed a culturally adapted questionnaire covering demographic details, vaccination history, health conditions, and perceptions related to the vaccines.
The onset of cardiac complications for the 27.11% of affected participants varied.
14.55% occurring within one month of vaccination, 6.97% between one and three months, and the rest experienced issues up to 12 months or more after receiving the vaccine.
For the 15.8% admitted to critical care units and 11.44% to general hospital wards, inpatient treatment lasted from less than one day to several weeks.
8.33% spent between four and seven days in the hospital.
Treatment for cardiac complications was ongoing for many participants.
9.45% received medical care for more than 12 months and 7.11% were undergoing continuous treatment at the time of the study.
Sixty-five percent of subjects reported being “neutral,” “somewhat not confident” or “not confident at all” on the safety of mRNA vaccines.
Meanwhile, only about 20% said they believed their cardiac symptoms were “strongly related” or “somewhat related” to the vaccines.
“Despite the bias of recruitment strategy to find patients with cardiovascular side effects from mRNA, these are large percentages requiring hospital and or ICU care,” McCullough said after analyzing the results of the study.
“More data are needed on these cases including diagnosis, treatment, and outcomes such as recurrent hospitalization and death,” he added.
The study’s authors emphasized the need for further investigation into the specific risk factors and biological mechanisms that may contribute to developing cardiac complications following vaccination.
TrialSite News called it “a strong study in regard to methodology, relevance, and ethical considerations.”
The outlet noted the authors seemed to “downplay the magnitude of the response,” despite what “seems like an awfully high rate” of cardiac complications.
link
Frank Bergman
April 5, 2024 - 12:54 pm
A top study conducted by a team of renowned microbiologists and immunologists has found that 27 percent of people vaccinated with Covid mRNA shots have damaged hearts.
The scientists found that many patients suffered major cardiac-related complications up to and over a year after receiving a Covid injection.
The study was led by microbiologist and immunologist Muazzam M. Sheriff and colleagues at Saudi Arabia’s Ibn Sina National College for Medical Studies and King Faisal General Hospital.
The results of the peer-reviewed study were published in the world-renowned Cureus medical journal.
Over a quarter of the participants in the study reported cardiac complications after receiving Covid mRNA shots.
Many of those patients required hospitalization or intensive care.
However, the scientists note that the study only recorded those who reported suffering cardiac-related complications.
Heart damage such as myocarditis often doesn’t have any symptoms until the sufferer experiences a major health issue such as cardiac arrest.
Therefore, the scientists warn that the true number of vaccinated people with heart damage could be far higher than they recorded due to the likelihood of large numbers of unreported cases.
Myocarditis is inflammation of the heart muscle (myocardium), according to Mayo Clinic.
The inflammation can reduce the heart’s ability to pump blood.
Severe myocarditis weakens the heart so that the rest of the body doesn’t get enough blood.
Clots can form in the heart, leading to a stroke, heart attack, or sudden death.
Experts now fear that undetected heart damage could be serving as a ticking time bomb among the Covid vaccinated.
The new study by Sheriff et al. revealed that 27.11% of the individuals they examined had received medical treatment for heart-related issues post-Covid vaccination.
The onset of cardiac complications varied among participants.
14.55% experienced symptoms within one month of vaccination.
However, others report issues up to 12 months or longer after receiving the shot.
The study warns that the findings suggest that the heart does not recover from the damage caused by the injections as previously claimed.
TrialSite News reported on the “bombshell Saudi Arabian study” this week.
Founder Daniel O’Connor stated that “the rate of hospitalized cases was certainly notable, especially given the existing cardiac (myocarditis/pericarditis) signal associated with the vaccines.”
Cardiologist and epidemiologist Dr. Peter A. McCullough said that in addition to the large number of cardiovascular symptoms warranting hospitalization, 15.8% landed in an intensive care unit (ICU).
“More than half of subjects indicated they were influenced by a healthcare professional or government agency to get vaccinated,” McCullough told The Defender.
“Never in recent times has there been such a cardiotoxic vaccine released on the public.”
Highlighting the growing concern surrounding the potential long-term effects of COVID-19 vaccines on cardiovascular health, O’Connor said:
“The surge in cardiac-related incidents in the news over the last year or two doesn’t comfort one either.”
The Saudi Arabian study employed a cross-sectional design and recruited 804 participants (379 men, and 425 women, ages 18 and above).
The participants had received at least one dose of an mRNA COVID-19 vaccine (Pfizer-BioNTech, Moderna, or both — 58 took a different brand).
Alarmingly, 40% of the participants had only received one shot.
Participants completed a culturally adapted questionnaire covering demographic details, vaccination history, health conditions, and perceptions related to the vaccines.
The onset of cardiac complications for the 27.11% of affected participants varied.
14.55% occurring within one month of vaccination, 6.97% between one and three months, and the rest experienced issues up to 12 months or more after receiving the vaccine.
For the 15.8% admitted to critical care units and 11.44% to general hospital wards, inpatient treatment lasted from less than one day to several weeks.
8.33% spent between four and seven days in the hospital.
Treatment for cardiac complications was ongoing for many participants.
9.45% received medical care for more than 12 months and 7.11% were undergoing continuous treatment at the time of the study.
Sixty-five percent of subjects reported being “neutral,” “somewhat not confident” or “not confident at all” on the safety of mRNA vaccines.
Meanwhile, only about 20% said they believed their cardiac symptoms were “strongly related” or “somewhat related” to the vaccines.
“Despite the bias of recruitment strategy to find patients with cardiovascular side effects from mRNA, these are large percentages requiring hospital and or ICU care,” McCullough said after analyzing the results of the study.
“More data are needed on these cases including diagnosis, treatment, and outcomes such as recurrent hospitalization and death,” he added.
The study’s authors emphasized the need for further investigation into the specific risk factors and biological mechanisms that may contribute to developing cardiac complications following vaccination.
TrialSite News called it “a strong study in regard to methodology, relevance, and ethical considerations.”
The outlet noted the authors seemed to “downplay the magnitude of the response,” despite what “seems like an awfully high rate” of cardiac complications.
link
